Tocilizumab inhibits IL‐8 and the proangiogenic potential of triple negative breast cancer cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tocilizumab inhibits IL‐8 and the proangiogenic potential of triple negative breast cancer cells
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume 60, Issue 1, Pages 51-59
Publisher
Wiley
Online
2020-12-03
DOI
10.1002/mc.23270
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of STAT3 signaling pathway in breast cancer
- (2020) Jia-hui Ma et al. Cell Communication and Signaling
- Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple‐negative breast cancer
- (2020) Noura N. Alraouji et al. MOLECULAR CARCINOGENESIS
- Breast cancer
- (2019) Nadia Harbeck et al. Nature Reviews Disease Primers
- Synergistic IL-6 and IL-8 paracrine signalling pathway infers a strategy to inhibit tumour cell migration
- (2017) Hasini Jayatilaka et al. Nature Communications
- Role of interleukin-6 in cancer progression and therapeutic resistance
- (2016) Neeraj Kumari et al. TUMOR BIOLOGY
- CD126 and Targeted Therapy with Tocilizumab in Chronic Lymphocytic Leukemia
- (2015) F.-T. Liu et al. CLINICAL CANCER RESEARCH
- Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary
- (2015) Nozomu Yanaihara et al. MOLECULAR CARCINOGENESIS
- Anti-proliferative action of IL-6R-targeted antibody tocilizumab for non-small cell lung cancer cells
- (2015) NA-HYUN KIM et al. Oncology Letters
- Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma
- (2015) Daiki Mochizuki et al. Oncotarget
- p16INK4A Represses Breast Stromal Fibroblasts Migration/Invasion and Their VEGF-A-dependent Promotion of Angiogenesis through Akt Inhibition
- (2015) Mysoon M. Al-Ansari et al. NEOPLASIA
- Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8
- (2013) Z. C. Hartman et al. CANCER RESEARCH
- Tumour endothelial cells acquire drug resistance in a tumour microenvironment
- (2013) K. Hida et al. JOURNAL OF BIOCHEMISTRY
- STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells
- (2013) M R Pawlus et al. ONCOGENE
- Lactate Influx through the Endothelial Cell Monocarboxylate Transporter MCT1 Supports an NF- B/IL-8 Pathway that Drives Tumor Angiogenesis
- (2011) F. Vegran et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models
- (2010) Yan Ning et al. INTERNATIONAL JOURNAL OF CANCER
- STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer
- (2010) Dimitrios Iliopoulos et al. MOLECULAR CELL
- Humanized Anti-Interleukin-6 Receptor Antibody Suppresses Tumor Angiogenesis and In vivo Growth of Human Oral Squamous Cell Carcinoma
- (2009) S. Shinriki et al. CLINICAL CANCER RESEARCH
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
- STAT3: A critical transcription activator in angiogenesis
- (2007) Zhong Chen et al. MEDICINAL RESEARCH REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started